Article

COVID-19: Impact on Canada’s pharmaceutical and retail pharmacy industry

A view of the unique challenges and opportunities

The coronavirus pandemic has affected Canada’s pharmaceutical and retail pharmacy industry across four main areas: product sourcing and procurement, product launch and distribution, acquisition and access, and treatment and care management. Based on challenges in these areas, this report offers a perspective on potential solutions and considerations.

Topics covered in this paper include:

  • How COVID-19 has affected the Canadian life sciences industry
  • Thinking through the unique challenges of COVID-19
  • Top challenges facing the industry
  • Opportunities to address key challenges and prepare for the future
  • Key considerations for successfully navigating through unprecedented times
Key contacts:

Shanil Ebrahim
Life Sciences & Health Care AI Leader

Lisa Purdy
Partner, National Life Sciences & Health Care Leader

Rob Lanoue
Partner, Customer Insights Leader

Did you find this useful?